Insights

Security is a problem, right? Well there's a radically different way to view it – as a positive force capable of putting clear water between you and your competitors. 

The medical implant industry is set to grow from $5bn in 2017 to $16.3bn by 2022. But there are tensions to understand and hurdles to overcome for innovators intent on taking advantage.

Patient monitoring is an inherent part of patient management. Intermittent and continuous measurements have a range of uses, from defining disease states and characterising progression to informing therapeutic approaches and...

Products are incorporating increasingly complex technology, putting greater pressure on the supply chain. As a result, gaps are forming and the risk to reputations and revenues is growing through issues such as...

Winning a prestigious international design award for our product innovation here at Cambridge Consultants is obviously fantastic – so scooping not just one but four gongs in the coveted iF Design Awards is great for everyone involved. Andy Pigeon, our head of User centred Design reviews the four winners.

The number of effective cell and gene therapies is growing rapidly, especially for treating ocular diseases. However, much less attention has been focused on the critical issue of delivery to the eye. 

If you’re a surgical robotics start-up, the timing of your risk assessment will determine the level of success you achieve. Andrew Savarese, VP, Surgical Robotics & Advanced Surgical Systems, delves into his deep experience and comes up with crucial advice to make sure you spend the right money once, not the wrong money twice.

The pandemic has compressed a decade of incremental change into a matter of months. Medical device companies sit on the cusp of radical change. Gavin Troughton, Head of Acute and Critical Care, surveys the fast changing landscape and poses the questions that can inform your digital transformation play…

Intraocular lens (IOL) delivery devices are the next frontier for innovation and differentiation. As the optical quality of the IOL is reaching its apex, there's little room for competitive differentiation in the lens itself. Tim Phillips explores the improvements to IOL delivery devices that could reduce complications, streamline delivery workflow and improve postoperative patient satisfaction.

With the increasing need for remote diagnosis and monitoring, telehealth solutions are on the rise. But how do you choose the correct data strategy to deal with the wealth of data – is there a trade off?

Intravitreal Injection Syringe: It is merely a pre-filled syringe, but is it?

As we enter 2021, the drive to adopt remote monitoring telemedicine techniques continues to gather pace. With the effects of the pandemic still reverberating around the world, healthcare providers are increasingly turning to a remote model to reduce infection risks.